Suzanne Hendrix
About
Suzanne Hendrix is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology.
According to data from OpenAlex, Suzanne Hendrix has authored 132 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Psychiatry and Mental health, 34 papers in Physiology and 28 papers in Pharmacology. Recurrent topics in Suzanne Hendrix's work include Dementia and Cognitive Impairment Research (41 papers), Alzheimer's disease research and treatments (26 papers) and Cholinesterase and Neurodegenerative Diseases (26 papers). Suzanne Hendrix is often cited by papers focused on Dementia and Cognitive Impairment Research (41 papers), Alzheimer's disease research and treatments (26 papers) and Cholinesterase and Neurodegenerative Diseases (26 papers). Suzanne Hendrix collaborates with scholars based in United States, United Kingdom and Germany. Suzanne Hendrix's co-authors include Kenton H. Zavitz, Edward A. Swabb, Mark Laughlin, Gordon Wilcock, Sandra E. Black, Jeffrey L. Cummings, Gene J. Ahlborn, Oscar A. Pike, C. S. Huber and Alireza Atri and has published in prestigious journals such as Neurology, The Lancet Neurology and Progress in Neurobiology.
In The Last Decade
Suzanne Hendrix
120 papers receiving 2.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Suzanne Hendrix United States | 25 | 1.1k | 846 | 526 | 318 | 268 | 132 | 2.2k | ||
| Peter Bentham United Kingdom | 28 | 989 0.9× | 1.2k 1.4× | 707 1.3× | 380 1.2× | 326 1.2× | 63 | 3.2k | ||
| Antonio Daniele Italy | 30 | 1.4k 1.2× | 640 0.8× | 407 0.8× | 320 1.0× | 455 1.7× | 89 | 3.2k | ||
| Shelia Jin United States | 16 | 1.5k 1.3× | 1.3k 1.5× | 907 1.7× | 608 1.9× | 390 1.5× | 28 | 3.9k | ||
| Aaron Ritter United States | 15 | 1.2k 1.1× | 544 0.6× | 630 1.2× | 329 1.0× | 556 2.1× | 44 | 2.4k | ||
| James Kost United States | 19 | 1.0k 0.9× | 811 1.0× | 369 0.7× | 233 0.7× | 322 1.2× | 34 | 2.5k | ||
| Christopher Ernesto United States | 11 | 1.5k 1.4× | 1.6k 1.9× | 709 1.3× | 439 1.4× | 466 1.7× | 11 | 3.6k | ||
| Samantha Rogers United Kingdom | 18 | 799 0.7× | 1.6k 1.9× | 1.3k 2.5× | 417 1.3× | 284 1.1× | 37 | 3.0k | ||
| Marwan Sabbagh United States | 9 | 1.9k 1.7× | 1.2k 1.4× | 536 1.0× | 687 2.2× | 731 2.7× | 14 | 3.7k | ||
| Edmond Teng United States | 27 | 1.2k 1.0× | 1.2k 1.4× | 296 0.6× | 338 1.1× | 324 1.2× | 80 | 2.6k | ||
| Ara S. Khachaturian United States | 25 | 1.8k 1.6× | 1.4k 1.6× | 863 1.6× | 627 2.0× | 733 2.7× | 51 | 4.3k |
Countries citing papers authored by Suzanne Hendrix
Since
Specialization
Citations
This map shows the geographic impact of Suzanne Hendrix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Hendrix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Hendrix more than expected).
Fields of papers citing papers by Suzanne Hendrix
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Suzanne Hendrix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Hendrix. The network helps show where Suzanne Hendrix may publish in the future.
Co-authorship network of co-authors of Suzanne Hendrix
This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Hendrix. A scholar is included among the top collaborators of Suzanne Hendrix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Hendrix. Suzanne Hendrix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Rubel, Carrie E., et al.. (2026). A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer’s disease. The Journal of Prevention of Alzheimer s Disease. 13(2). 100458–100458.
2.
Kupiec, James W., Raymond Scott Turner, Suzanne Hendrix, et al.. (2026). Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer’s disease. The Journal of Prevention of Alzheimer s Disease. 13(3). 100469–100469.
3.
Kaplan, Johanne, et al.. (2025). Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(4). e70183–e70183.
4.
Haaland, Benjamin, Samuel P. Dickson, Rudolph E. Tanzi, et al.. (2025). Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial. Journal of Alzheimer s Disease. 108(1). 234–242.
5.
Hendrix, Suzanne, Mary Sano, Constantine G. Lyketsos, et al.. (2025). Cohen-mansfield agitation inventory total score as a measure of agitation and aggression in Alzheimer’s disease: A factor analysis. International Psychogeriatrics. 37(3). 100056–100056.
6.
Arnold, Steven E., Suzanne Hendrix, Jessie Nicodemus‐Johnson, et al.. (2024). Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(3). e12487–e12487.
7.
L’Italien, Gilbert, Samuel P. Dickson, Jordan Dubow, et al.. (2024). Re-weighting MDS-UPDRS Motor Items for Optimal Sensitivity to Parkinson’s Disease Progression in Untreated Patients Using Parkinson’s Progression Markers Initiative Data (S2.004). Neurology. 102(7_supplement_1).
8.
Phan, H., Ayesha Ahmad, Janet A. Thomas, et al.. (2024). Results of the ACTION‐Galactosemia Kids Study to Evaluate the Effects of Govorestat in Pediatric Patients with Classic Galactosemia. The Journal of Clinical Pharmacology. 65(5). 575–587.
9.
Wessels, Alette M., Ellen B. Dennehy, Sherie A. Dowsett, Samuel P. Dickson, & Suzanne Hendrix. (2023). Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings. Neurology Clinical Practice. 13(2). e200127–e200127.
10.
Lindblom, Nina, Lars Lindquist, Jacob Westman, et al.. (2021). Potential Virus Involvement in Alzheimer’s Disease: Results from a Phase IIa Trial Evaluating Apovir, an Antiviral Drug Combination. Journal of Alzheimer s Disease Reports. 5(1). 413–431.
11.
Hendrix, Suzanne, Hilkka Soininen, Anneke M.J. van Hees, et al.. (2019). Alzheimer's Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease. The Journal of Prevention of Alzheimer s Disease. 6(4). 232–236.
12.
Ropacki, Michael T., Kristín Hannesdóttir, Suzanne Hendrix, et al.. (2017). Clinically Meaningful Outcomes in Early Alzheimer Disease: A Consortia-Driven Approach to Identifying What Matters to Patients. Therapeutic Innovation & Regulatory Science. 51(3). 380–390.
13.
Abushakra, Susan, Anton P. Porsteinsson, B. Vellas, et al.. (2016). CLINICAL BENEFITS OF TRAMIPROSATE IN ALZHEIMER’S DISEASE ARE ASSOCIATED WITH HIGHER NUMBER OF APOE4 ALLELES: THE “APOE4 GENE-DOSE EFFECT”. The Journal of Prevention of Alzheimer s Disease. 3(4). 1–10.
14.
Alva, Gustavo, Noel Ellison, Biplob Dass, & Suzanne Hendrix. (2016). Daily Functioning Benefits of Adding Memantine to Stable Cholinesterase Treatment in Patients with Moderate to Severe Alzheimer’s Disease: A Post Hoc Pooled Factor Analysis (P2.218). Neurology. 86(16_supplement).
15.
Schneeberger, Achim, Suzanne Hendrix, Markus Mandler, et al.. (2015). RESULTS FROM A PHASE II STUDY TO ASSESS THE CLINICAL AND IMMUNOLOGICAL ACTIVITY OF AFFITOPE® AD02 IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE. The Journal of Prevention of Alzheimer s Disease. 2(2). 1–12.
16.
Hendrix, Suzanne, Andrew Koenig, Wenzhi Li, & Amitabh Singh. (2013). Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis. Journal of International Medical Research. 41(5). 1606–1611.
17.
Hendrix, Suzanne. (2012). Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time. Alzheimer s Research & Therapy. 4(4). 24–24.
18.
Galasko, Douglas, N. R. Graff-Radford, Susanne May, et al.. (2007). Safety, Tolerability, Pharmacokinetics, and Aβ Levels After Short-term Administration of R-flurbiprofen in Healthy Elderly Individuals. Alzheimer Disease & Associated Disorders. 21(4). 292–299.
19.
Ballif-Spanvill, Bonnie, et al.. (2003). Gender, types of conflict, and individual differences in the use of violent and peaceful strategies among children who have and have not witnessed interparental violence.. American Journal of Orthopsychiatry. 73(2). 141–153.
20.
Hendrix, Suzanne, et al.. (2001). Pen Or Printer: Can Students Afford to Handwrite Their Exams?. Journal of legal education. 51. 118.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Peter Bentham Breakdown of academic impact, for papers by Antonio Daniele Breakdown of academic impact, for papers by Shelia Jin Breakdown of academic impact, for papers by Aaron Ritter Breakdown of academic impact, for papers by James Kost Breakdown of academic impact, for papers by Christopher Ernesto Breakdown of academic impact, for papers by Samantha Rogers Breakdown of academic impact, for papers by Marwan Sabbagh Breakdown of academic impact, for papers by Edmond Teng Breakdown of academic impact, for papers by Ara S. Khachaturian